March 1, 2023 -- BioAuxilium Research this week announced the expansion of its no-wash Thunder time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio at the annual Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in San Diego.
The company, a biotech tool company focused on facilitating access to fully validated assay kits to the biomedical research community, introduced six new biomarker research assay kits, a reader control kit, and an enhanced assay development service for drug discovery research.
BioAuxilium said it developed the new biomarker assays in response to customer requests for reliable cell-based assays that provide an alternative to expensive immunoassay platforms such as other TR-FRET and bead-based assay technologies.
The new offerings include a panel of six key mouse inflammatory cytokines (CCL-2/MCP1, IFN-beta, IFN-gamma, IL-2, IL-6, and TNF-alpha), expanding the company's portfolio to a total of 100 cell-based assay kits. The ready-to-use reader control kit allows users to assess in just 10 minutes the suitability of TR-FRET compatible microplate readers to perform Europium-based TR-FRET measurements, the firm said.